Atomoxetine - treatment of attention deficit hyperactivity disorder: beyond stimulants.

Thomason C; Michelson D

首页> 外文期刊>Drugs of today: Medicamentos de actualidad >Atomoxetine - treatment of attention deficit hyperactivity disorder: beyond stimulants.

【24h】

Atomoxetine - treatment of attention deficit hyperactivity disorder: beyond stimulants.

机译：Atomoxetine-注意缺陷多动障碍的治疗：兴奋剂以外。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Among the pharmacotherapeutic interventions for attention deficit hyperactivity disorder (ADHD), psychostimulants have been the drugs of choice for many years. However, some patients do not adequately respond to or cannot tolerate stimulant treatment. Among nonstimulants for ADHD, the most extensively studied and the only one approved for use in the United States is the norepinephrine reuptake inhibitor atomoxetine. This paper reviews atomoxetine's chemistry and putative mechanism of action, as well as its clinical pharmacokinetics, metabolism, and efficacy and safety in acute clinical trials. (c) 2004 Prous Science. All rights reserved.

著录项

来源
《Drugs of today: Medicamentos de actualidad》 |2004年第5期|共9页
作者
Thomason C; Michelson D;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学;
关键词
Child attention deficit disorder; therapeutic aspects; STIMULANTS; reuptake;

机译：儿童注意缺陷障碍;治疗方面;STIMULANTS;再摄取;

相似文献

外文文献
中文文献
专利

1. Atomoxetine - treatment of attention deficit hyperactivity disorder: beyond stimulants. [J] . Thomason C, Michelson D Drugs of today: Medicamentos de actualidad . 2004,第5期

机译：Atomoxetine-注意缺陷多动障碍的治疗：兴奋剂以外。
2. Atomoxetine in the Treatment of the Most Common Comorbid Disorders of Attention-Deficit/Hyperactivity Disorder, Oppositional Defiant Disorder and Anxiety Disorders [J] . E. Snircova, T. Kulhan, G. Nosalova, Acta Medica Martiniana . 2012,第3期

机译：阿托莫西汀用于治疗注意力缺陷/多动障碍，对立违抗性障碍和焦虑症等最常见的合并症
3. Visual function and ocular features in children and adolescents with attention deficit hyperactivity disorder, with and without treatment with stimulants. [J] . Gronlund MA, Aring E, Landgren M, Eye . 2007,第4期

机译：患有或未患有兴奋剂治疗的患有注意力缺陷多动障碍的儿童和青少年的视觉功能和眼部功能。
4. A Survey of Technologies Utilized in the Treatment and Diagnosis of Attention Deficit Hyperactivity Disorder [C] . Lauren E. Johnson, James M. Conrad IEEE Annual Ubiquitous Computing, Electronics Mobile Communication Conference . 2018

机译：注意缺陷多动障碍的治疗和诊断技术综述
5. Use of attention deficit/hyperactivity disorder pharmacological treatment following the public discussion on cardiovascular safety and the introduction of medication guides for central nervous system stimulants and atomoxetine. [D] . Chen, Chih-Ying. 2010

机译：在对心血管安全进行公开讨论并引入中枢神经系统兴奋剂和阿托西汀的用药指南后，使用注意缺陷/多动障碍药物治疗。
6. Differences between children and adolescents in treatment response to atomoxetine and the correlation between health-related quality of life and Attention Deficit/Hyperactivity Disorder core symptoms: Meta-analysis of five atomoxetine trials [O] . Peter M Wehmeier, Alexander Schacht, Rodrigo Escobar, 2010

机译：儿童和青少年对阿托西汀治疗反应的差异以及与健康相关的生活质量与注意力缺陷/多动障碍的核心症状之间的相关性：五个阿托西汀试验的荟萃分析
7. Differences between children and adolescents in treatment response to atomoxetine and the correlation between health-related quality of life and Attention Deficit/Hyperactivity Disorder core symptoms: Meta-analysis of five atomoxetine trials [O] . Peter M Wehmeier, Alexander Schacht, Rodrigo Escobar, 2010

机译：儿童和青少年对阿托西汀治疗反应的差异以及与健康相关的生活质量与注意力缺陷/多动障碍的核心症状之间的相关性：五个阿托西汀试验的荟萃分析

Atomoxetine - treatment of attention deficit hyperactivity disorder: beyond stimulants.

摘要

著录项

相似文献

相关主题

期刊订阅